Microbes hobble a widely used chemo drug | Science News

SUPPORT SCIENCE NEWS

Science News is a nonprofit.

Help us keep you informed.


News in Brief

Microbes hobble a widely used chemo drug

In mice, antibiotics helped the cancer treatment regain its power

By
2:00pm, September 14, 2017
tumor cells with bacteria

STRONGER TOGETHER  Tumor cells (red) grown with bacteria (green) could stave off a common chemotherapy drug because some bacteria can inactivate the drug.

Some bacteria may shield tumor cells against a common chemotherapy drug.

Certain types of bacteria make an enzyme that inactivates the drug gemcitabine, researchers report in the Sept. 15 Science. Gemcitabine is used to treat patients with pancreatic, lung, breast and bladder cancers.

Bacteria that produce the enzyme cytidine deaminase converted the drug to an inactive form. That allowed tumor cells to survive gemcitabine treatment in lab dishes and mouse studies, Leore Geller of the Weizmann Institute of Science in Rehovot, Israel, and colleagues discovered. More than 98 percent of the enzyme-producing microbes belong to the Gammaproteobacteria class, which includes E. coli and about 250 bacterial genera.

Pancreatic tumors taken from human patients also carried the enzyme-producing bacteria. Of 113 pancreatic ductal adenocarcinoma samples studied, 86 contained gemcitabine

This article is only available to Science News subscribers. Already a subscriber? Log in now. Or subscribe today for full access.

Get Science News headlines by e-mail.

More from this issue of Science News

From the Nature Index Paid Content